NewsAvi Kapoor
Pharming Group NV
PHAR · NYSE
$11.20+$0.53 (+4.97%)TodayMarket closed ·
Prev close $10.67
Latest news
- NewsAvi Kapoor
Crude Oil Moves Higher; Lockheed Martin Posts Upbeat Earnings
- NewsAvi Kapoor
Healthcare Services Posts Upbeat Q3 Earnings, Joins Pool, Spotify And Other Big Stocks Moving Higher On Thursday
- Press releaseGlobe Newswire
Pharming Group announces third quarter 2026 revenues above market expectations
- Press releaseGlobe Newswire
Pharming presents positive Phase II topline data for leniolisib in genetic PIDs with immune dysregulation at ESID 2026
- Press releaseGlobe Newswire
Pharming announces CEO transition
- Press releaseGlobe Newswire
Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS
- Press releaseGlobe Newswire
Pharming announces positive Phase II topline data for leniolisib in PIDs with immune dysregulation accepted as late-breaking abstract at ESID 2026
- Press releaseGlobe Newswire
FDA approves Pharming’s Joenja® as first treatment for children with APDS in the U.S.
- Press releaseGlobe Newswire
Pharming Group to participate in September investor conferences
- Press releaseGlobe Newswire
Pharming announces commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older
- Press releasePRNewswire
Pharming Group (PHAR) Securities Investigation Notice - Levi & Korsinsky
- Press releaseBusiness Wire
Securities Fraud Investigation Into Pharming Group N.V. (PHAR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
- Press releaseBusiness Wire
Pharming Group N.V. (PHAR) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
- Press releaseBusiness Wire
Securities Fraud Investigation Into Pharming Group N.V. (PHAR) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
- Press releaseBusiness Wire
PHAR Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Pharming Group (PHAR)
- Press releasePRNewswire
PHAR SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Pharming Group
- Press releasePRNewswire
Pharming Group Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Pharming Group (PHAR)
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsAvi Kapoor
Meta Posts Mixed Q2 Results, Joins Coursera, Qualcomm And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
- Press releaseGlobe Newswire
Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic use
- Press releaseGlobe Newswire
Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS
- Press releaseGlobe Newswire
Pharming Group to participate in Fireside Chat at 2026 Jefferies Global Healthcare Conference in New York
- Press releaseGlobe Newswire
European Commission grants marketing authorization to Pharming's Joenja® (leniolisib) – the first approved treatment for APDS in the European Union
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseGlobe Newswire
Pharming Group to participate in April investor conferences
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
- Press releaseGlobe Newswire
Pharming Group to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR
- Press releaseGlobe Newswire
Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day
- NewsAvi Kapoor
Argenx, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- NewsAvi Kapoor
Pharming Group Posts Upbeat Q3 Results, Joins On Holding, BigBear.ai Holdings And Other Big Stocks Moving Higher On Wednesday
- News
Earnings Scheduled For November 6, 2025
- Press releaseGlobe Newswire
Pharming Group to participate in Fireside Chat at Jefferies Global Healthcare Conference in London
- NewsAvi Kapoor
Concentrix Posts Downbeat Earnings, Joins Legacy Education, Kingsoft Cloud And Other Big Stocks Moving Lower In Friday's Pre-Market Session
- NewsAvi Kapoor
Why Top KingWin Shares Are Trading Higher By 87%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
Pharming Group to present at the H.C. Wainwright 27th Annual Global Investment Conference
- News
Earnings Scheduled For May 8, 2025
- News
What Analysts Are Saying About Pharming Stock
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.